Investing.com

By Sam Boughedda  BofA analysts said in a note to clients Wednesday that the firm remains cautious on Underperform rated Doximity, Inc. (NYSE:DOCS). The analysts, who have a $27...

By Sam Boughedda  Oppenheimer analysts cut the firm's price target on banking stocks such as Goldman Sachs (NYSE:GS), Citigroup (NYSE:C), Morgan Stanley (NYSE:MS), JPMorgan...

By Sam Boughedda  Northland Capital Markets analysts selected Generac Holdings (NYSE:GNRC) as a 'Top Pick' for 2023, maintaining an Outperform rating and a $180 per share price...

By Sam Boughedda  In a note Wednesday morning, Sevens Report Research said the start of 2023 isn't the time to allocate to growth. In this morning's research note, the firm stated...

Amid the biggest ratings changes in the past week, Tesla was slashed at Oppenheimer and suffered another painful tumble in the past five sessions. Here are all of this past week's...

By Sam Boughedda  Piper Sandler analysts maintained an Overweight rating and a $30 per share price target on Pinterest (NYSE:PINS) in a note, telling investors the firm sees an...

By Sam Boughedda  Wells Fargo analysts said in a note on biotechnology stocks on Friday that for Biogen (NASDAQ:BIIB), a $25,000 to $30,000 annual price could still be appropriate...

By Liz Moyer, Peter Nurse, Scott Kanowsky and Yasin Ebrahim Investing.com -- The year is heading to a close on a sour note with the hoped-for Santa rally failing to materialize....

By Sam Boughedda  On Thursday, The Financial Times reported that BlackRock (NYSE:BLK) discussed pursuing a takeover of The Carlyle Group (NASDAQ:CG) but decided against it. The...

By Sam Boughedda  In a note to clients on Wednesday, Evercore ISI analysts said that loyalty models like Costco (NASDAQ:COST) and BJ's Wholesale Club (NYSE:BJ) are well-positioned...